Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19



Rating:

Share or cite this content

Citations should be made in the following way:
i. nouira (ariana, Tunisia), S. Maazaoui (ariana, Tunisia), S. Marzouki (ariana, Tunisia), S. Habibech (ariana, Tunisia), M. Chaabene (ariana, Tunisia), H. Racil (ariana, Tunisia), N. Chaouech (ariana, Tunisia). Prognosis value of hypertension in Covid-19 infection. 293

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Determinants and prognostic value of kidney disease in pulmonary arterial hypertension Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Incidence of pulmonary hypertension in hyperthyroidism Source: Eur Respir J 2003; 22: Suppl. 45, 465s Year: 2003 Diagnosis of pulmonary hypertension Source: Eur Respir J, 53 (1) 1801904; 10.1183/13993003.01904-2018 Year: 2019 Diagnosis and management of persistent pulmonary hypertension of the newborn Source: Annual Congress 2013 –The lung's "first golden hours" in life: alveolar and vascular transition at birth Year: 2013 Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Diabetes mellitus as cause of treatment failure and relapses of pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 311s Year: 2001 Prevalence, risk factors and prognosis of pulmonary hypertension in cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Long-term outcome of sarcoidosis-associated pulmonary hypertension in the modern treatment era Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Diagnosis and treatment of secondary pulmonary hypertension in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006 Pulmonary arterial hypertension associated to HIV infection Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Effect of vaccination of pneumococcal infection on the course of chronic obstructive pulmonary disease in combination with diabetes mellitus Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019 Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 332-338 Year: 2009 Severe pulmonary hypertension in patients with emphysema but preserved FEV1: Prognosis and response to treatment Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Prognosis in pulmonary arterial hypertension Source: Eur Respir J 2011; 37: 971-972 Year: 2011 Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 Year: 2021 Predicting survival in pulmonary arterial hypertension in the UK}, Source: Eur Respir J 2012; 40: 604-611 Year: 2012 Predictors of poor outcome in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012